Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - IPO
 More »

  • Young Companies in the Money: 25 Firms to Watch
    The combination private-IPO financings reflected the recovery in earnest of the initial public offering (IPO) market after nearly a decade of inactivity, especially during the ...
    10-2-2013
  • Regado Axes 15% of Staff, Focuses on Phase III Trial
    Regado shrunk its workforce some five weeks after completing an IPO that raised only $47 ... adjusts following disappointing $47M IPO last month. Regado Axes 15% of Staff, ...
    9-27-2013
  • As Big Deals Resurface, Who's Next to the Altar?
    Amgen-Onyx, Perrigo-Elan warm an M&A space that had been chilled by an IPO revival. Amgen's planned acquisition of Onyx Pharmaceuticals was a reminder of how quiet the M&A market ...
    9-9-2013
  • Valeant Acquiring Bausch + Lomb for $8.7B
    The deal comes some two months after Bausch + Lomb filed for an initial public offering seeking to raise up to $100 million. The IPO was filed following news reports that Warburg ...
    5-28-2013
  • Scratching and Clawing for Sales
    ... Waiting for Zoetis The largest animal pharma player, Pfizer, is expected within weeks to spin off its animal health unit through an initial public offering. The IPO identifies the ...
    1-15-2013
  • The Big Idea for 2009 as Discussed at J.P. Morgan
    The serious cash crunch has created the need for small-cap companies to look for synergies through a partner or merger. IPO activity is unlikely till the Q4, and early-stage ...
    8-13-2012
  • Biotech M&A in 2012
    The bad news for the IPO market should mean good news for biotechnology M&As in 2012, and for the most part it does. However, premiums or multiples paid per deal vary ...
    5-23-2012
  • M&A Likely to Continue Growing Along with Deal Premiums and Multiples
    Slow comeback of IPO market will keep companies looking for opportunities to be acquired. The long-dormant biopharma IPO market continues to take a few steps forward then a few ...
    5-23-2012
  • Buyout Options Gaining a Foothold in Deals Means that More than...
    ... Even if the budding recovery of the IPO market over this past year sticks, it likely will ... And the IPO market is far from healthy; the latest IPO, Rib-X Pharmaceuticals postponed a ...
    5-16-2012
  • GEN Poll Respondents 'Somewhat' Optimistic VC Market Will Improve...
    The remaining 3.1% were undecided. Despite recent signs of life in the IPO market, the migration of venture capital from biopharma companies stepped up during the first three ...
    5-9-2012
  • Market Divergence Indicative of New Normal
    ... to hold onto (and fund) private companies prior to an IPO event continues to lengthen. ... More than 80% of the 2011 biopharma IPO class had drug candidates in Phase III development ...
    5-1-2012
  • MannKind Out-Licenses BTK Program to Tolero
    For MannKind, the money obtained through this deal will help move Afrezza beyond Phase III. MannKind's IPO took place in July 2004, and it has been investing in development of ...
    4-30-2012
  • 2012 Financing
    The migration of venture capital from biopharma companies stepped up during the first three months of 2012, despite recent signs of life in the IPO market. The dollar value of VC ...
    4-24-2012
  • Venture Capital Continues Its Migration in Q1 2012 as Investors...
    three months of 2012, seemingly unaffected by recent signs of life in the IPO market. ... uncertainty in biopharma financing is the performance of the long-dormant IPO market. ...
    4-24-2012
  • 2012 Has the Makings of a Breakout Year
    ... Seeking Alternatives to a Tepid U.S. IPO Market While 2011 saw several biopharma IPO success stories-including NewLink Genetics and Clovis Oncology, both late-stage cancer ...
    4-1-2012

  • Journal Articles

  • Perioperative Analysis of Laparoscopic Liver Resection with Different...
    JingWang Tan, YunChang Tan, YuLi Zhu, Ke Chen, Benshun Hu, HuaMin Tan, XiangMin Ding, JianJun Leng, Fei Chen, JiaHong Dong
    Journal of Laparoendoscopic& Advanced Surgical Techniquesand Part B, Videoscopy
    intermittent total pedicle occlusion (IPO), hemihepatic vascular occlusion (HVO), and ... occlusion methods, including 15 cases of IPO, 15 cases of HVO, and 11 cases of SVO. The ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll